Advertisement

Extracellular ATP and β-NAD alter electrical properties and cholinergic effects in the rat heart in age-specific manner

  • Ksenia B. Pustovit
  • Viktoria M. Potekhina
  • Alexandra D. Ivanova
  • Alexey M. Petrov
  • Denis V. Abramochkin
  • Vlad S. KuzminEmail author
Original Article

Abstract

Extracellular ATP and nicotinamide adenine dinucleotide (β-NAD) demonstrate properties of neurotransmitters and neuromodulators in peripheral and central nervous system. It has been shown previously that ATP and β-NAD affect cardiac functioning in adult mammals. Nevertheless, the modulation of cardiac activity by purine compounds in the early postnatal development is still not elucidated. Also, the potential influence of ATP and β-NAD on cholinergic neurotransmission in the heart has not been investigated previously. Age-dependence of electrophysiological effects produced by extracellular ATP and β-NAD was studied in the rat myocardium using sharp microelectrode technique. ATP and β-NAD could affect ventricular and supraventricular myocardium independent from autonomic influences. Both purines induced reduction of action potentials (APs) duration in tissue preparations of atrial, ventricular myocardium, and myocardial sleeves of pulmonary veins from early postnatal rats similarly to myocardium of adult animals. Both purine compounds demonstrated weak age-dependence of the effect. We have estimated the ability of ATP and β-NAD to alter cholinergic effects in the heart. Both purines suppressed inhibitory effects produced by stimulation of intracardiac parasympathetic nerve in right atria from adult animals, but not in preparations from neonates. Also, ATP and β-NAD suppressed rest and evoked release of acetylcholine (ACh) in adult animals. β-NAD suppressed effects of parasympathetic stimulation and ACh release stronger than ATP. In conclusion, ATP and β-NAD control the heart at the postsynaptic and presynaptic levels via affecting the cardiac myocytes APs and ACh release. Postsynaptic and presynaptic effects of purines may be antagonistic and the latter demonstrates age-dependence.

Keywords

Heart Cholinergic effects Postnatal development β-NAD ATP Purine cotransmitters 

Abbreviations

ACh

Acetylcholine

AF

Atrial fibrillation

AP

Action potential

APD

Action potential duration

APD90

Action potential duration at 90% of repolarization

LA

Left atrium

NST

Neostigmine

P1

1st day of postnatal development

P14

14st day of postnatal development

P21

21st day of postnatal development

PV

Pulmonary vein

RA

Right atrium

RV

Right ventricular wall

SAP

Spontaneous action potential

β-NAD

β-nicotinamide adenine dinucleotide

Notes

Author contributions

Participated in the study planning: Kuzmin VS.

Performed experiments and data analysis: Pustovit KB, Potekhina VM, Ivanova AD.

Contributed to the discussion and reviewed/edited the manuscript: Petrov AM.

Wrote the manuscript: Abramochkin DV, Kuzmin VS.

Funding information

This study was supported by Russian Science Foundation grant 14-15-00268.

Compliance with ethical standards

Conflicts of interest

Pustovit KB declares that she has no conflict of interest.

Potekhina VM declares that she has no conflict of interest.

Ivanova AD declares that she has no conflict of interest.

Petrov AM declares that he has no conflict of interest.

Abramochkin DV declares that he has no conflict of interest.

Kuzmin VS declares that he has no conflict of interest.

Ethical approval

This study was approved by Bioethics Committee of Moscow State University.

References

  1. 1.
    Hoyle CH, Burnstock G (1986) Evidence that ATP is a neurotransmitter in the frog heart. Eur J Pharmacol 124:285–289Google Scholar
  2. 2.
    Burnstock G (2009) Purinergic cotransmission. F1000 Biol Rep 1:46.  https://doi.org/10.3410/B1-46 Google Scholar
  3. 3.
    Burnstock G (2013) Cotransmission in the autonomic nervous system. Handb Clin Neurol 117:23–35.  https://doi.org/10.1016/B978-0-444-53491-0.00003-1 Google Scholar
  4. 4.
    Kennedy C (2015) ATP as a cotransmitter in the autonomic nervous system. Auton Neurosci 191:2–15.  https://doi.org/10.1016/j.autneu.2015.04.004 Google Scholar
  5. 5.
    Alefishat E, Alexander SPH, Ralevic V (2015) Effects of NAD at purine receptors in isolated blood vessels. Purinergic Signal 11:47–57.  https://doi.org/10.1007/s11302-014-9428-1 Google Scholar
  6. 6.
    Mutafova-Yambolieva VN, Hwang SJ, Hao X, Chen H, Zhu MX, Wood JD, Ward SM, Sanders KM (2007) Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci U S A 104:16359–16364.  https://doi.org/10.1073/pnas.0705510104 Google Scholar
  7. 7.
    Hwang SJ, Blair PJ, Durnin L, Mutafova-Yambolieva V, Sanders KM, Ward SM (2012) P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit. J Physiol 590:1957–1972.  https://doi.org/10.1113/jphysiol.2011.224634 Google Scholar
  8. 8.
    Mutafova-Yambolieva VN, Durnin L (2014) The purinergic neurotransmitter revisited: a single substance or multiple players. Pharmacol Ther 144:162–191.  https://doi.org/10.1016/j.pharmthera.2014.05.012 Google Scholar
  9. 9.
    Burnstock G, Hoyle CH (1985) Actions of adenine dinucleotides in the Guinea-pig taenia coli: NAD acts indirectly on P1-purinoceptors; NADP acts like a P2-purinoceptor agonist. Br J Pharmacol 84:825–831Google Scholar
  10. 10.
    Pustovit KB, Kuzmin VS, Sukhova GS (2015) Effect of exogenous extracellular nicotinamide adenine dinucleotide (nad+) on bioelectric activity of the pacemaker and conduction system of the heart. Bull Exp Biol Med 159(2):188–191.  https://doi.org/10.1007/s10517-015-2919-4 Google Scholar
  11. 11.
    Smyth LM, Bobalova J, Mendoza MG, Lew C, Mutafova-Yambolieva VN (2004) Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J Biol Chem 279:48893–48903.  https://doi.org/10.1074/jbc.M407266200 Google Scholar
  12. 12.
    Ribeiro JA, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54:213–218Google Scholar
  13. 13.
    Ribeiro JA, Cunha RA, Correia-de-Sa P, Sebastiao AM (1996) Purinergic regulation of acetylcholine release. Prog Brain Res 109:231–241Google Scholar
  14. 14.
    Burnstock G, Cocks T, Crowe R, Kasakov L (1978) Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol 63:125–138Google Scholar
  15. 15.
    Breen LT, Smyth LM, Yamboliev IA, Mutafova-Yambolieva VN (2006) Beta-NAD is a novel nucleotide released on stimulation of nerve terminals in human urinary bladder detrusor muscle. Am J Physiol Renal Physiol 290:F486–F495.  https://doi.org/10.1152/ajprenal.00314.2005 Google Scholar
  16. 16.
    Cheung K, Ryten M, Burnstock G (2003) Abundant and dynamic expression of G protein-coupled P2Y receptors in mammalian development. Dev Dyn 228(2):254–266.  https://doi.org/10.1002/dvdy.10378 Google Scholar
  17. 17.
    Bogdanov Y, Rubino A, Burnstock G (1998) Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. Life Sci 62(8):697–703Google Scholar
  18. 18.
    Webb TE, Boluyt MO, Barnard EA (1996) Molecular biology of P2Y purinoceptors: expression in rat heart. J Auton Pharmacol 16:303–307Google Scholar
  19. 19.
    Tsai KJ, Tsai YC, Shen CK (2007) G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 204(6):1273–1280Google Scholar
  20. 20.
    Petrov AM, Naumenko NV, Uzinskaya KV, Giniatullin AR, Urazaev AK, Zefirov AL (2011) Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter. Neuroscience 186:1–12.  https://doi.org/10.1016/j.neuroscience.2011.04.051 Google Scholar
  21. 21.
    Odnoshivkina UG, Sytchev VI, Nurullin LF, Giniatullin AR, Zefirov AL, Petrov AM (2015) β2-adrenoceptor agonist-evoked reactive oxygen species generation in mouse atria: implication in delayed inotropic effect. Eur J Pharmacol 765:140–153.  https://doi.org/10.1016/j.ejphar.2015.08.020 Google Scholar
  22. 22.
    Abramochkin DV, Nurullin LF, Borodinova AA, Tarasova NV, Sukhova GS, Nikolsky EE, Rosenshtraukh LV (2010) Non-quantal release of acetylcholine from parasympathetic nerve terminals in the right atrium of rats. 95(2):265–273.  https://doi.org/10.1113/expphysiol.2009.050302
  23. 23.
    Anikina TA, Bilalova GA, Zverev AA, Sitdikov FG (2007) Effect of ATP and its analogs on contractility of rat myocardium during ontogeny. Bull Exp Biol Med 144:4–7.  https://doi.org/10.1007/s10517-007-0239-z Google Scholar
  24. 24.
    Vassort G (2001) Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767–806Google Scholar
  25. 25.
    Kuzmin VS, Pustovit KB, Abramochkin DV (2016) Effects of exogenous nicotinamide adenine dinucleotide (NAD+) in the rat heart are mediated by P2 purine receptors. J Biomed Sci 23(50):50.  https://doi.org/10.1186/s12929-016-0267-y Google Scholar
  26. 26.
    Doisne N, Maupoil V, Cosnay P, Findlay I (2009) Catecholaminergic automatic activity in the rat pulmonary vein: electrophysiological differences between cardiac muscle in the left atrium and pulmonary vein. Am J Physiol Heart Circ Physiol 297(1):H102–H108.  https://doi.org/10.1152/ajpheart.00256.2009 Google Scholar
  27. 27.
    Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666Google Scholar
  28. 28.
    Schotten U, Verheule S, Kirchhof P, Goette A (2011) Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 91(1):265–325Google Scholar
  29. 29.
    Sharma AD, Klein GJ (1988) Comparative quantitative electrophysiologic effects of adenosine triphosphate on the sinus node and atrioventricular node. Am J Cardiol 61:330–335Google Scholar
  30. 30.
    Pelleg A, Belhassen B (2010) The mechanism of the negative chronotropic and dromotropic actions of adenosine 5′-triphosphate in the heart: an update. J Cardiovasc Pharmacol 56:106–109.  https://doi.org/10.1097/FJC.0b013e3181e0f8b2 Google Scholar
  31. 31.
    Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661.  https://doi.org/10.3389/fphar.2017.00661 Google Scholar
  32. 32.
    Pelleg A (2017) Electrophysiologic effects of adenosine versus ATP. J Cardiovasc Electrophysiol 28:E5.  https://doi.org/10.1111/jce.13243 Google Scholar
  33. 33.
    Billington RA, Bruzzone S, De Flora A, Genazzani AA, Koch-Nolte F, Ziegler M, Zocchi E (2006) Emerging functions of extracellular pyridine nucleotides. Mol Med 12:324–327.  https://doi.org/10.2119/2006-00075 Google Scholar
  34. 34.
    Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F, Koch-Nolte F (2009) Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal 5:139–149.  https://doi.org/10.1007/s11302-009-9135-5 Google Scholar
  35. 35.
    Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4(1):1–20.  https://doi.org/10.1007/s11302-007-9078-7 Google Scholar
  36. 36.
    Hwang S, Blair P, Durnin L, Mutafova-Yambolieva V, Sanders K, Ward S (2012) P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit. J Physiol 590(8):1957–1972.  https://doi.org/10.1113/jphysiol.2011.224634 Google Scholar
  37. 37.
    Moreschi I, Bruzzone S, Nicholas RA, Fruscione F, Sturla L, Benvenuto F, Usai C, Meis S, Kassack MU, Zocchi E, De Flora A (2006) Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem 281:31419–31429.  https://doi.org/10.1074/jbc.M606625200 Google Scholar
  38. 38.
    Dreisig K, Kornum BR (2016) A critical look at the function of the P2Y11 receptor. Purinergic Signal 12(3):427–437.  https://doi.org/10.1007/s11302-016-9514-7 Google Scholar
  39. 39.
    Kennedy C (2017) P2Y(11) receptors: properties, distribution and functions. Adv Exp Med Biol 1051:107–122.  https://doi.org/10.1007/5584 Google Scholar
  40. 40.
    Nishimura A, Sunggip C, Oda S, Numaga-Tomita T, Tsuda M, Nishida M (2017) Purinergic P2Y receptors: molecular diversity and implications for treatment of cardiovascular diseases. Pharmacol Ther 180:113–128.  https://doi.org/10.1016/j.pharmthera.2017.06.010 Google Scholar
  41. 41.
    Abramochkin DV, Tapilina SV, Sukhova GS, Nikolsky EE, Nurullin LF (2012) Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart. Pflugers Arch 463(4):523–529.  https://doi.org/10.1007/s00424-012-1075-1 Google Scholar
  42. 42.
    Wang H, Lu Y, Wang Z (2007) Function of cardiac M3 receptors. Auton Autocoid Pharmacol 27:1–11.  https://doi.org/10.1111/j.1474-8673.2006.00381.x Google Scholar
  43. 43.
    Tapilina SV, Abramochkin DV (2016) Decrease in the sensitivity of myocardium to M3 muscarinic receptor stimulation during postnatal ontogenisis. Acta Nat 8(2):127–131Google Scholar
  44. 44.
    Wootten D, Christopoulos A, Marti-Solano M, Babu MM, Sexton PM (2018) Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol 19:638–653.  https://doi.org/10.1038/s41580-018-0049-3 Google Scholar
  45. 45.
    Glitsch HG, Pott L (1978) Effects of acetylcholine and parasympathetic nerve stimulation on membrane potential in quiescent guinea-pig atria. J Physiol 279:655–668Google Scholar
  46. 46.
    Takei M, Furukawa Y, Narita M, Ren LM, Karasawa Y, Murakami M, Chiba S (1991) Synergistic nonuniform shortening of atrial refractory period induced by autonomic stimulation. Am J Phys 261:H1988–H1993Google Scholar
  47. 47.
    Chiba S (1978) Selective stimulation of intracardiac pre-ganglionic vagal fibres of the dog atrium. Clin Exp Pharmacol Physiol 5:465–469Google Scholar
  48. 48.
    Ribeiro JA, Walker J (1973) Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius. Br J Pharmacol 49:724–725Google Scholar
  49. 49.
    Ribeiro J, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54(2):213–218Google Scholar
  50. 50.
    Guarracino JF, Cinalli AR, Fernandez V, Roquel LI, Losavio AS (2016) P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction. Neuroscience 326:31–44.  https://doi.org/10.1016/j.neuroscience.2016.03.066 Google Scholar
  51. 51.
    Ribeiro JA, Dominguez ML (1978) Mechanisms of depression of neuromuscular transmission by ATP and adenosine. J Physiol 74:491–496Google Scholar
  52. 52.
    Pelleg A, Hurt CM, Hewlett EL (1996) ATP shortens atrial action potential duration in the dog: role of adenosine, the vagus nerve, and G protein. Can J Physiol Pharmacol 74:15–22Google Scholar
  53. 53.
    Marvin WJ Jr, Hermsmeyer K, McDonald RI, Roskoski LM, Roskoski R Jr (1980) Ontogenesis of cholingergic innervation in the rat heart. Circ Res 46(5):690–695Google Scholar
  54. 54.
    Vyskocil F, Malomouzh AI, Nikolsky EE (2009) Non-quantal acetylcholine release at the neuromuscular junction. Physiol Res 58(6):763–784Google Scholar
  55. 55.
    Nassenstein C, Wiegand S, Lips KS, G4 L, Klein J, Kummer W (2015) Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters. 29(1):173–180.  https://doi.org/10.1016/j.intimp.2015.08.007
  56. 56.
    Malomouzh AI, Nikolsky EE, Vyskocil F (2011) Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm. Neurosci Res 71:219–225.  https://doi.org/10.1016/j.neures.2011.07.1829 Google Scholar
  57. 57.
    Galkin AV, Giniatullin RA, Mukhtarov MR, Svandova I, Grishin SN, Vyskocil F (2001) ATP but not adenosine inhibits nonquantal acetylcholine release at the mouse neuromuscular junction. Eur J Neurosci 13:2047–2053Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Human and Animal PhysiologyLomonosov Moscow State UniversityMoscowRussia
  2. 2.Department of PhysiologyPirogov Russian National Research Medical UniversityMoscowRussia
  3. 3.Institute of NeuroscienceKazan State Medial UniversityKazanRussia
  4. 4.Laboratory of Biophysics of Synaptic ProcessesKazan Institute of Biochemistry and Biophysics, Federal Research Center “Kazan Scientific Center of RAS”KazanRussia
  5. 5.Laboratory of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural DivisionRussian Academy of SciencesSyktyvkarRussia

Personalised recommendations